Want to see DE:93M1 full AI Analyst Report?
Top Page
MPH Health Care AG
(XETRA:93M1)
Select Model
Select Model
Rating:74Outperform
Price Target:
€32.00
▲(27.49% Upside)
Action:Reiterated
Date:09/06/26
The score is driven primarily by solid valuation (low P/E and very high dividend yield) and supportive technical strength (price above key moving averages with positive momentum). These positives are offset by the main fundamental risk: uneven cash-flow generation and highly volatile revenues despite improved profitability and a strong, low-debt balance sheet.
Positive Factors
Low financial leverage
Very low debt relative to equity gives MPH substantial financial flexibility over the medium term. Conservative financing reduces interest and refinancing pressure, supports resilience when portfolio values or distributions fluctuate, and preserves capacity to manage or develop healthcare investments.
Negative Factors
Highly erratic revenue
Sharp revenue swings make the company’s top-line earnings power difficult to predict over the next several quarters. For a holding company, uneven results may reflect changes in investment activity or portfolio outcomes, reducing confidence that reported profitability represents a stable recurring trend.
Read all positive and negative factors
Positive Factors
Negative Factors
Low financial leverage
Very low debt relative to equity gives MPH substantial financial flexibility over the medium term. Conservative financing reduces interest and refinancing pressure, supports resilience when portfolio values or distributions fluctuate, and preserves capacity to manage or develop healthcare investments.
Read all positive factors
MPH Health Care AG (93M1) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€120.31M
Dividend Yield17.79%
Average Volume (3M)1.72K
Price to Earnings (P/E)1.1
Beta (1Y)0.66
Revenue Growth-62.35%
EPS GrowthN/A
CountryDE
Employees2
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)25.01
Shares Outstanding4,281,384
10 Day Avg. Volume1,855
30 Day Avg. Volume1,723
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio765.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.7
Revenue Forecast (FY)€41.20M
MPH Health Care AG Business Overview & Revenue Model
Company Description
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and va...
How the Company Makes Money
MPH Health Care AG primarily makes money through its role as a holding company that owns stakes in healthcare-related businesses. Its earnings are typically generated from (1) dividends and profit distributions received from portfolio companies (w...
MPH Health Care AG Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
84
Very Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 358.93M | 364.30M | 6.11M | 7.24M | 6.85M | 4.36M |
| Gross Profit | 358.90M | 364.30M | 6.11M | 125.94M | 6.80M | 4.01M |
| EBITDA | 112.79M | 34.10M | 33.32M | 30.36M | 29.68M | -9.05M |
| Net Income | 107.05M | 29.30M | 32.04M | 29.54M | 29.11M | -8.96M |
Balance Sheet | ||||||
| Total Assets | 266.68M | 258.09M | 291.06M | 266.35M | 236.99M | 198.00M |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 1.37M | 1.20M | 5.10M | 3.82M | 4.44M |
| Total Debt | 15.37M | 11.63M | 10.56M | 13.05M | 12.99M | 4.05M |
| Total Liabilities | 18.27M | 14.68M | 13.19M | 15.39M | 15.57M | 5.69M |
| Stockholders Equity | 248.41M | 243.41M | 277.87M | 250.97M | 221.42M | 192.31M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 123.01K | 1.83M | -2.02M | -170.41K | -1.28M |
| Operating Cash Flow | 11.02M | 130.88K | 1.83M | -2.02M | -164.79K | -1.28M |
| Investing Cash Flow | -3.79M | -3.29M | 3.40M | 5.40M | -8.96M | 6.37M |
| Financing Cash Flow | -11.85M | -6.85M | -7.70M | 7.74M | -3.02M | -3.61M |
MPH Health Care AG Technical Analysis
Positive
25.10
Price Trends
26.35
Positive
25.18
Positive
21.67
Positive
Market Momentum
0.52
Positive
57.30
Neutral
47.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:93M1, the sentiment is Positive. The current price of 25.1 is below the 20-day moving average (MA) of 27.49, below the 50-day MA of 26.35, and above the 200-day MA of 21.67, indicating a bullish trend. The MACD of 0.52 indicates Positive momentum. The RSI at 57.30 is Neutral, neither overbought nor oversold. The STOCH value of 47.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:93M1.
MPH Health Care AG Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €120.31M | 1.12 | 43.53% | 17.79% | -62.35% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | €1.89B | 14.01 | 22.38% | 2.27% | 0.39% | 38.58% | |
51 Neutral | €18.96M | -1.33 | -127.78% | ― | ― | ― | |
41 Neutral | €507.75M | -2.58 | -26.46% | ― | -7.72% | -26.61% |
* Financial Sector Average
DE:93M1
MPH Health Care AG
27.90
12.94
86.51%
DE:B8FK
Biofrontera
3.10
0.43
16.10%
DE:EVT
Evotec
2.84
-4.03
-58.64%
DE:PA8
PAION AG
0.05
0.03
283.33%
DE:DMP
Dermapharm Holding SE
38.70
6.56
20.40%
DE:SBX
SynBiotic SE
0.17
-2.47
-93.45%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.